+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Pruritus Global Clinical Trials Review, H1, 2020

  • ID: 5118401
  • Clinical Trials
  • May 2020
  • Region: Global
  • 323 pages
  • GlobalData

FEATURED COMPANIES

  • Cara Therapeutics Inc
  • GlaxoSmithKline Plc
  • Helsinn Group
  • Menlo Therapeutics Inc
  • Novartis AG
  • Sanofi
  • MORE
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Summary

The publisher's clinical trial report, “Pruritus Global Clinical Trials Review, H1, 2020" provides an overview of Pruritus Clinical trials scenario. This report provides top line data relating to the clinical trials on Pruritus. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). The publisher's Clinical Trial Reports are generated using the publisher's proprietary database - Pharma - Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Scope
  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months
Reasons to Buy
  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Cara Therapeutics Inc
  • GlaxoSmithKline Plc
  • Helsinn Group
  • Menlo Therapeutics Inc
  • Novartis AG
  • Sanofi
  • MORE
Report Guidance

Clinical Trials Report Coverage
  • Clinical Trials by Region
  • Clinical Trials and Average Enrollment by Country
  • Top Five Countries Contributing to Clinical Trials in Asia-Pacific
  • Top Five Countries Contributing to Clinical Trials in Europe
  • Top Countries Contributing to Clinical Trials in North America
  • Top Five Countries Contributing to Clinical Trials in Middle East and Africa
  • Top Five Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Pruritus to Dermatology Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Pruritus to Dermatology Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
Clinical Trials by Phase
  • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Subjects Recruited Over a Period of Time
Clinical Trials by Sponsor Type
  • Prominent Sponsors
  • Top Companies Participating in Pruritus Therapeutics Clinical Trials
  • Prominent Drugs
  • Latest Clinical Trials News on Pruritus
  • Mar 10, 2020: Asana BioSciences announces topical sodium channel blocker ASN008 achieves positive results for the treatment of Pruritus in Atopic Dermatitis
  • Feb 26, 2020: Menlo Therapeutics announces results from Phase 2 trial of Serlopitant in patients with chronic pruritus of unknown origin
  • Feb 25, 2020: Vanda reports results from the EPIONE study of tradipitant in the treatment of pruritus in atopic dermatitis
  • Feb 10, 2020: Elorac to present Naloxone Lotion Phase III study update at the 4th World Congress of Cutaneous Lymphomas in Barcelona
  • Clinical Trial Profile Snapshots
Appendix
  • Abbreviations
  • Definitions
  • Research Methodology
  • Secondary Research
  • About the Publisher
  • Contact
  • Source
List of Tables
  • Pruritus Therapeutics, Global, Clinical Trials by Region, 2020*
  • Pruritus Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2020*
  • Pruritus Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2020*
  • Pruritus Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2020*
  • Pruritus Therapeutics Clinical Trials, Europe, Top Five Countries, 2020*
  • Pruritus Therapeutics Clinical Trials, North America, Top Countries, 2020*
  • Pruritus Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2020*
  • Pruritus Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2020*
  • Proportion of Pruritus to Dermatology Clinical Trials, G7 Countries (%), 2020*
  • Pruritus Therapeutics, G7 Countries, Clinical Trials by Phase, 2020*
  • Pruritus Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2020*
  • Proportion of Pruritus to Dermatology Clinical Trials, E7 Countries (%), 2020*
  • Pruritus Therapeutics, E7 Countries, Clinical Trials by Phase, 2020*
  • Pruritus Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2020*
  • Pruritus Therapeutics, Global, Clinical Trials by Phase, 2020*
  • Pruritus Therapeutics, Global, Clinical Trials In Progress by Phase 2020*
  • Pruritus Therapeutics, Global, Clinical Trials by Trial Status, 2020*
  • Pruritus Therapeutics Clinical Trials, Global, by End Point Status, 2020*
  • Pruritus Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2015-2019
  • Pruritus Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2020*
  • Pruritus Therapeutics Clinical Trials, Global, Key Sponsors, 2020*
  • Pruritus Therapeutics Clinical Trials, Global, Top Companies by Phase, 2020*
  • Pruritus Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2020*
List of Figures
  • Pruritus Therapeutics, Global, Clinical Trials by Region (%), 2020*
  • Pruritus Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2020*
  • Pruritus Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2020*
  • Pruritus Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2020*
  • Pruritus Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2020*
  • Pruritus Therapeutics Clinical Trials, North America, Top Countries (%), 2020*
  • Pruritus Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2020*
  • Pruritus Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2020*
  • Proportion of Pruritus to Dermatology Clinical Trials, G7 Countries (%), 2020*
  • Pruritus Therapeutics, G7 Countries, Clinical Trials by Phase, 2020*
  • Pruritus Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2020*
  • Proportion of Pruritus to Dermatology Clinical Trials, E7 Countries (%), 2020*
  • Pruritus Therapeutics, E7 Countries, Clinical Trials by Phase, 2020*
  • Pruritus Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2020*
  • Pruritus Therapeutics, Global, Clinical Trials by Phase (%), 2020*
  • Pruritus Therapeutics, Global, Clinical Trials In Progress by Phase, 2020*
  • Pruritus Therapeutics, Global, Clinical Trials by Trial Status, 2020*
  • Pruritus Therapeutics Clinical Trials, Global, by End Point Status, 2020*
  • Pruritus Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2015-2019
  • Pruritus Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2020*
  • Pruritus Therapeutics Clinical Trials, Global, Key Sponsors, 2020*
  • Pruritus Therapeutics Clinical Trials, Global, Top Companies by Phase, 2020*
  • Pruritus Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2020*
  • Methodology
Note: Product cover images may vary from those shown
  • Cara Therapeutics Inc
  • UCB SA
  • Helsinn Group
  • GlaxoSmithKline Plc
  • Sanofi
  • Trevi Therapeutics Inc
  • Menlo Therapeutics Inc
  • Toray Industries Inc
  • Novartis AG
  • Sienna Biopharmaceuticals Inc
Note: Product cover images may vary from those shown
Adroll
adroll